ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeki Morita
Munetaka Masuda
Ryuji Tominaga
Yoshito Kawachi
Hisataka Yasui
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishida, T.
Right arrow Articles by Yasui, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, T.
Right arrow Articles by Yasui, H.

Ann Thorac Surg 1998;66:1647-1652
© 1998 The Society of Thoracic Surgeons

Lazaroid U74500A is superior to U74006F in preserving rabbit heart for 24 hours

Takahiro Nishida, MDa, Shigeki Morita, MDa, Munetaka Masuda, MDa, Ryuji Tominaga, MDa, Yoshito Kawachi, MDa, Hisataka Yasui, MDa

a Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan

Accepted for publication May 17, 1998.

Address reprint requests to Dr Morita, Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
e-mail: (morita{at}heart.med.kyushu-u.ac.jp)

Background. Lazaroid, a series of 21-aminosteroids, has been shown to reduce free-radical–mediated injury after ischemia and reperfusion. Recent in vitro studies have demonstrated that, among the various compounds studied, the most efficient agent was U74500A. The question is whether these findings apply to the whole heart experiencing ischemia-reperfusion injury. In this study we compared the myocardial protective effects of U74006F, the only clinical candidate, and U74500A.

Methods. An isolated rabbit heart preparation perfused with the blood from a support rabbit was used. All hearts were divided into three groups according to the administration of U74500A (4 mg/kg, group A; n = 7), U74006F (4 mg/kg, group F; n = 7), or solvent (group S; n = 7) to the donor rabbit before preservation. After 24 hours of preservation with University of Wisconsin solution at 0°C, all hearts were perfused with cross-circulated blood for 60 minutes with the Langendorff mode followed by 40 minutes in the working mode.

Results. After 10 minutes of reperfusion the serum lipid peroxide levels were significantly (p < 0.05) lower in group A (0.62 ± 0.31 nmol/mL) than those in group S (2.1 ± 1.3 nmol/mL) and group F (1.0 ± 0.6 nmol/mL). The aortic flow rate at 10 mm Hg of left atrial pressure was significantly higher in group A (164 ± 37 mL/min) than that of other groups (71 ± 28 mL/min in group S and 97 ± 28 mL/min in group F). There were no significant differences in high-energy phosphate levels after reperfusion among the three groups.

Conclusion. These data imply that U74500A inhibits lipid peroxidation and prevents ischemia-reperfusion injury more efficiently than U74006F.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.